INJECTION SITE DERMATITIS

This adverse event was reported 144 times

These drugs are most commonly taken by patients reporting INJECTION SITE DERMATITIS:

# Drug Count
0 TERIPARATIDE 25
1 DUPILUMAB 14
2 INTERFERON BETA-1A 9
3 ETANERCEPT 8
4 TIRZEPATIDE 8
5 ADALIMUMAB 7
6 FUROSEMIDE 5
7 RIBAVIRIN 5
8 GLATIRAMER ACETATE 4
9 DULAGLUTIDE 3
See all common drugs associated with INJECTION SITE DERMATITIS

INJECTION SITE DERMATITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BULEVIRTIDE 1 0.0104
1 IBALIZUMAB 1 0.0019
2 CAPLACIZUMAB 1 0.0006
3 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 1 0.0005
4 ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) 1 0.0004
5 SOTALOL HYDROCHLORIDE TABLES AF 1 0.0004
6 SOTALOL HYDROCHLORIDE TABLETS AF 1 0.0004
7 LEVONORGESTREL AND ETHINYL ESTRADIOL 1 0.0004
8 IPRATROPIUM BROMIDE AND ALBUTEROL 1 0.0004
9 1168 BURN SPRAY 1 0.0003
See all drugs enriched for association with INJECTION SITE DERMATITIS